The Role of Pathogenic Mutations in Colorectal Cancer
International Journal of Pathology and Biomarkers · 2025
DOI: 10.71428/ijpb.2025.0102 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pathology and Biomarkers, 2025. Verfasst von Ghufran Merie und 1 weiteren Autor:innen. Die Arbeit nennt 81 Literaturangaben.
Abstract (Originalsprache)
One of the most common cancers in the world, colorectal cancer (CRC) is influenced by both environmental and genetic factors. Pathogenic mutations are among the genetic factors that are crucial to the development, course, and response to treatment of colorectal cancer. Unchecked cell proliferation, apoptosis evasion, and metastasis result from key mutations in genes like APC, KRAS, TP53, PIK3CA, and SMAD4 that disrupt important signalling pathways like Wnt/β-catenin, MAPK, PI3K/AKT, and TGF-β. Furthermore, germline mutations in the APC gene and DNA mismatch repair genes, respectively, are the cause of hereditary syndromes such as Lynch syndrome and Familial Adenomatous Polyposis (FAP). We now have a better understanding of these mutations thanks to developments in genomic profiling, which enables more individualized treatment strategies. The main pathogenic mutations linked to colorectal cancer (CRC) are highlighted in this review along with their biological significance, diagnostic implications, and potential as therapeutic targets.
Zitieren
APA
Merie, G., & Al-hashimi, H. (2025). The Role of Pathogenic Mutations in Colorectal Cancer. International Journal of Pathology and Biomarkers. https://doi.org/10.71428/ijpb.2025.0102
Vancouver
Merie G, Al-hashimi H. The Role of Pathogenic Mutations in Colorectal Cancer. International Journal of Pathology and Biomarkers. 2025. doi:10.71428/ijpb.2025.0102
BibTeX
@article{Merie2025,
author = {Merie, Ghufran and Al-hashimi, Hadeel},
title = {The Role of Pathogenic Mutations in Colorectal Cancer},
journal = {International Journal of Pathology and Biomarkers},
year = {2025},
doi = {10.71428/ijpb.2025.0102}
}
EUVIMED